Although significant (p < 0.05), this difference suggests that MMs harbor fairly modest increases of MET-GCN as compared to other cancer types such as NSCLC, in which de novo high-level MET-amplification, often with more than 15 MET gene copies (“gene clusters”), can be detected by FISH analysis [16,17]. The gene discussed is MET; the disease is cancer.